DYDC1
DPY30 domain-containing protein 1
Also known as: bA36D19.5, DPY30D1, DYDC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WWB3
- Gene
- DYDC1
- Ensembl
- ENSG00000170788
- Chromosome
- 10
- Canonical length
- 177 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Mid piece,Principal piece,End piece
OverviewNCBI Gene
This gene encodes a member of a family of proteins that contains a DPY30 domain. The encoded protein is involved in acrosome formation during spermatid development. This gene locus overlaps with a closely related gene on the opposite strand. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
177 residues, UniProt reviewed canonical sequence.
>Q8WWB3|DYDC1
1 MESIYLQKHL GACLTQGLAE VARVRPVDPI EYLALWIYKY KENVTMEQLR QKEMAKLERE
61 RELALMEQEM MERLKAEELL LQQQQLALQL ELEMQEKERQ RIQELQRAQE QLGKEMRMNM
121 ENLVRNEDIL HSEEATLDSG KTLAEISDRY GAPNLSRVEE LDEPMFSDIA LNIDQDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DYDC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 114 nTPM
Expression across tissuesHPA
Tissue
- testis: 114 nTPM
- fallopian tube: 5.3 nTPM
- choroid plexus: 1.4 nTPM
- epididymis: 1.4 nTPM
- lung: 0.9 nTPM
- cervix: 0.2 nTPM
Single-cell type
- late primary spermatocytes: 809 nCPM
- early spermatids: 171 nCPM
- early primary spermatocytes: 89 nCPM
- late spermatids: 87 nCPM
- respiratory ciliated cells: 74 nCPM
- fallopian tube ciliated cells: 45 nCPM
Immune cell
- basophil: 1.7 nTPM
- NK-cell: 0.3 nTPM
- memory B-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- neutrophil: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- choroid plexus: 4.8 nTPM
- midbrain: 1.9 nTPM
- spinal cord: 1.7 nTPM
- medulla oblongata: 1.3 nTPM
- basal ganglia: 1.2 nTPM
- hypothalamus: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DYDC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DYDC1 as an antibody target. Whether an autoantibody or antibody against DYDC1 could matter depends on whether native DYDC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DYDC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DYDC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...